CSIMarket
 


Iqvia Holdings Inc   (IQV)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Iqvia Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

IQV's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

IQV Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth 24.09 % 39.28 % 42.65 % 49.54 % 10.69 %
Y / Y Current Assets Growth 12.35 % 9.6 % 8.51 % 11.65 % 4.58 %
Working Capital Ratio for Trailing Twelve Months Period 1.13 1.15 1.22 1.3 1.42
Total Ranking # 2054 # 3203 # 3334 # 3489 # 4002
Seq. Current Liabilities Growth -1.24 % 1.11 % -2.71 % 27.74 % 10.85 %
Seq. Current Assets Growth 7.45 % -2.27 % 0.02 % 6.97 % 4.82 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to decrease in Current Liabilities in the IV. Quarter to $4,692 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 1.13 below Iqvia Holdings Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 20 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Iqvia Holdings Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about IQV
Working Capital Ratio IQV in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 21
Sector # 414
S&P 500 # 1710


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.6 1.19 0.82
(Dec 31 2015)   (Dec 31 2023)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Laboratories Industry Working Capital Ratio for Trailing Twelve Months Period
Ispecimen inc   3.02 
American Shared Hospital Services  2.86 
Luna Innovations Inc  2.81 
Exact Sciences Corporation  2.67 
Biocept Inc   2.57 
Fortrea Holdings Inc   2.50 
Inotiv Inc   2.08 
Psychemedics Corp  1.99 
Charles River Laboratories International inc   1.91 
Enzo Biochem Inc  1.87 
Genetron Holdings Ltd  1.82 
Biodesix Inc   1.51 
Centogene N v   1.49 
Laboratory Corporation Of America Holdings  1.41 
Quest Diagnostics Inc  1.38 
Foxo Technologies Inc   1.27 
Icon Plc  1.21 
Medpace Holdings Inc   1.20 
Koninklijke Philips Nv  1.19 
Iqvia Holdings Inc   1.17 
Ge Healthcare Technologies Inc   1.15 
Syneos Health Inc   1.14 
Radnet Inc   1.13 
Renalytix Plc  1.09 
National Research Corporation  0.94 
Opgen inc   0.78 
Malachite Innovations Inc   0.77 
Aclarion Inc   0.76 
Evolutionary Genomics Inc   0.35 
Fresh2 Group Ltd  0.32 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com